Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer
Clinical trial NCT03580395 · UNKNOWN
Trial details
- NCT number
- NCT03580395
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2022-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.